Tenax CFO granted shares and 450K stock options
Tenax Therapeutics reported a Form 4 showing its Chief Financial Officer, Thomas R. Staab II, receiving new equity compensation.
Rhea-AI Filing Summary
Tenax Therapeutics reported a Form 4 showing its Chief Financial Officer, Thomas R. Staab II, receiving new equity compensation. He was granted 10,000 shares of common stock as a restricted stock award and 450,000 stock options with an exercise price of $11.95 per share.
The restricted stock vests 25% ten days after the grant date of May 11, 2026, with the remaining 75% vesting in three equal installments on the four-month, eight-month and twelve-month anniversaries, contingent on continued employment. The options expire on May 11, 2036 and vest 25% on May 11, 2027, with the balance vesting in substantially equal monthly installments over the following 36 months, also subject to continued employment.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 460,000 shares
Grant/Award
2 txns
Insider
STAAB THOMAS R II
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 450,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 10,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 450,000 contracts (Direct);
Common Stock — 10,000 shares (Direct)
Footnotes (2)
- F1. Represents a restricted stock award which vests 25% ten days after the grant date, with the remainder vesting in three equal installments on the four-month, eight-month and twelve-month anniversaries of the grant date, subject to the Reporting Person's continued employment.
- F2. The options vest and become exercisable as follows: 25% vest on May 11, 2027, and thereafter, the remainder vest in substantially equal installments on each monthly anniversary of the grant date for a period of 36 months, subject to the Reporting Person's continued employment.
Key Figures
Restricted stock award: 10,000 shares
Stock options granted: 450,000 options
Option exercise price: $11.95 per share
+2 more
5 metrics
Restricted stock award
10,000 shares
Common stock granted to CFO on May 11, 2026
Stock options granted
450,000 options
Right to buy Tenax common stock
Option exercise price
$11.95 per share
Strike price for 450,000 options
Options expiration
May 11, 2036
Final date to exercise options
Post-grant share holdings
10,000 shares
CFO common stock directly held after grant
Key Terms
restricted stock award, stock option, exercise price, vesting, +1 more
5 terms
restricted stock award financial
"Represents a restricted stock award which vests 25% ten days after the grant date"
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
stock option financial
"The options vest and become exercisable as follows: 25% vest on May 11, 2027"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "11.9500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"the remainder vesting in three equal installments on the four-month, eight-month and twelve-month anniversaries"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date": "2036-05-11T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity compensation did Tenax Therapeutics (TENX) CFO receive?
The CFO received 10,000 shares of common stock as a restricted stock award and 450,000 stock options. The options carry an exercise price of $11.95 per share and expire on May 11, 2036, forming part of his long-term incentive package.
How do the Tenax (TENX) CFO’s restricted stock awards vest?
The 10,000-share restricted stock award vests 25% ten days after the May 11, 2026 grant date. The remaining 75% vests in three equal installments on the four-month, eight-month, and twelve-month anniversaries, conditioned on the CFO’s continued employment with Tenax Therapeutics.
What is the vesting schedule for the Tenax (TENX) CFO’s stock options?
The 450,000 stock options vest 25% on May 11, 2027. The remaining options then vest in substantially equal installments on each monthly anniversary of the grant date for 36 months, subject to the CFO’s continued employment, providing long-term equity exposure.
What is the exercise price and expiration date of the Tenax (TENX) CFO options?
The stock options granted to the CFO have an exercise price of $11.95 per share. They expire on May 11, 2036, giving a long-dated right to purchase Tenax Therapeutics common stock if vesting and employment conditions are satisfied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
